The magazine used Securities and Exchange Commission filings, its own reporting and that of its affiliates to compile the rankings.
- Medtronic: $31.7 billion
- Johnson & Johnson MedTech: $27.1 billion
- Siemens Healthineers: $20.5 billion
- Royal Philips: $20.3 billion
- Medline Industries: $20.2 billion
- GE HealthCare: $17.7 billion
- Stryker: $17.1 billion
- Cardinal Health (medical segment): $15.9 billion
- Abbott (medical device segment): $14.4 billion
- Baxter: $12.8 billion
- Henry Schein: $12.4 billion
- Boston Scientific: $11.9 billion
- Owens & Minor: $9.8 billion
- BD (medical segment): $9.5 billion
- B. Braun Melsungen: $9.3 billion
- 3M Co. (healthcare segment): $9.1 billion
- Alcon: $8.2 billion
- Fujifilm Holdings (healthcare only): $7.3 billion
- Zimmer Biomet (minus ZimVie spinoff): $6.8 billion
- Olympus (medical business): $6.7 billion
- Terumo: $6.4 billion
- Intuitive Surgical: $5.7 billion
- Hologic: $5.6 billion
- Edwards Lifesciences: $5.2 billion
- Smith+Nephew: $5.2 billion
- Steris: $4.6 billion
- Fresenius Medical Care (healthcare products): $4.4 billion
- Canon Medical: $4.4 billion
- Dentsply Sirona: $4.3 billion
- BioMérieux: $4 billion
- Align Technology: $4 billion
- Mindray: $3.9 billion
- Hoya (life care segment): $3.7 billion
- Sonova: $3.7 billion
- ResMed: $3.6 billion
- Nipro (medical segment): $3.4 billion
- Getinge: $3.2 billion
- Coloplast: $3 billion
- Demant: $2.9 billion
- Bio-Rad: $2.9 billion
- Cooper Cos.: $2.9 billion
- Teleflex: $2.8 billion
- Paul Hartmann: $2.7 billion
- HU Group: $2.5 billion
- Dexcom: $2.4 billion
- Dräger (medical division): $2.4 billion
- Bruker: $2.4 billion
- Cook Medical: $2.3 billion
- Amplifon: $2.3 billion
- Straumann: $2.2 billion
- ConvaTec: $2 billion
- Carl Zeiss Meditec: $2 billion
- Nihon Kohden: $1.9 billion
- Elekta: $1.7 billion
- Integra Lifesciences: $1.5 billion
- Enovis (formerly Colfax’s medical technology segment, DJO): $1.4 billion
- ICU Medical: $1.3 billion
- Masimo: $1.2 billion
- Cochlear: $1.2 billion
- Integer: $1.2 billion
- Omron Healthcare: $1.2 billion
- Fukuda Denshi: $1.2 billion
- Fisher & Paykel Healthcare: $1.2 billion
- NuVasive: $1.1 billion
- Insulet: $1.1 billion
- Merit Medical Systems: $1 billion
- LivaNova: $1 billion
- Abiomed: $1 billion
- ZimVie (formerly Zimmer Biomet’s spine and dental business): $1 billion
- Conmed: $1 billion
- Konica Minolta (healthcare segment): $1 billion
- Haemonetics: $993.2 million
- Globus Medical: $958.1 million
- Invacare: $872.5 million
- GN Hearing: $849 million
- Cordis: $788 million
- MicroPort: $778.6 million
- Avanos Medical: $744.6 million
- Össur: $719 million
- Asahi Intecc (medical field segment): $667.8 million
- Nikkiso (medical segment): $665.9 million
- Ambu: $613.8 million
- Agfa-Gevaert (radiology solutions segment): $547.5 million
- Novocure: $535 million
- JMS Co.: $529.6 million
- Topcon (eye care business): $520.2 million
- Natus Medical: $473.4 million
- Orthofix: $464.5 million
- Accuray: $429.9 million
- Medacta: $428.5 million
- Nevro: $386.9 million
- iRhythm: $322.8 million
- Barco (healthcare division): $308.6 million
- Artivion (formerly CryoLife): $298.8 million
- Glaukos: $294 million
- Inari Medical: $277 million
- AtriCure: $274.3 million
- Alphatec: $243.2 million
- Shockwave Medical: $237.1 million
- Cardiovascular Systems: $236.2 million
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
